AKCA News and Press, Akcea Therapeutics Inc.

Pfizer (PFE) has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-L) in statin-treated patients with elevated non-high-density lipoprotein cholesterol (non-HDL-C) and triglycerides (TGs), says Ionis Pharmaceuticals (IONS) and its subsidiary Akcea Therapeutics (AKCA).The study, Targetin...

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product PR Newswire BOSTON and CARLSBAD, Calif., Oct. 30, 2020 BOSTON and CARLSBAD, Calif. , Oct. 30, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, In...

Merger activity moderated again last week with three new deals announced. The acquisition of Acorn International by First Ostia Port. The merger of DouYu International Holdings Limited and HUYA Inc. For further details see: Merger Arbitrage Mondays - 2 Potential Deals Co...

Ionis Pharmaceuticals ([[IONS]] +0.6%) acquires 100% ownership of Akcea Therapeutics ([[AKCA]]) which accelerates the next phase of Ionis' growth and positions it to better deliver more medicines to patients while maximizing value to all stakeholders.Under the terms, Akcea shareholders w...

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics Transaction creates a stronger, more efficient company PR Newswire CARLSBAD, Calif., Oct. 12, 2020 CARLSBAD, Calif. , Oct. 12, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS...

NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Akcea Therapeutics, Inc. (NASDAQ: AKCA ), relating...

NEW YORK, NY / ACCESSWIRE / September 21, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sal...

NEW YORK, NY / ACCESSWIRE / September 20, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Akcea Therapeutics, Inc . ( AKCA ) relating t...

Akcea Therapeutics (NASDAQ: AKCA ) , majority-owned affiliate of Ionis Pharmaceuticals (NASDAQ: IONS )   announces that the National Institute for Health and Care Excellence (NICE) has issued a positive Final Evaluation Document for WAYLIVRA (volanesorsen) for the treatment of Famili...

NEW YORK, NY / ACCESSWIRE / September 17, 2020 / Sadeh LLP, a global investor rights law firm, is investigating: Akcea Therapeutics, Inc. (NASDAQ:AKCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Io...